Evidence map›Paper›PMID 30813960›Full record

ArticleJournal for immunotherapy of cancer2019

The immune suppressive microenvironment of human gliomas depends on the accumulation of bone marrow-derived macrophages in the center of the lesion.

Laura Pinton, Elena Masetto, Marina Vettore, Samantha Solito, Sara Magri, Marta D'Andolfi, Paola Del Bianco, Giovanna Lollo, Jean-Pierre Benoit, Hideho Okada and 3 more

Open access · goldAbstract read
In one paragraph

Article in Journal for immunotherapy of cancer, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 114 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
114citing papers in PubMed, 1 pooled it
9.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

114 citing papers in PubMed, 1 synthesis or guideline pooled it, 166 citations in OpenAlex.

  1. Pooled it
  2. Single-cell and bulk transcriptome analysis reveals the impact of inflammatory microglia on prognosis and immunotherapy response in primary glioblastoma.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Piezo1-related physiological and pathological processes in glioblastoma.Frontiers in cell and developmental biology · 2025
    Review
  20. Article

54 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 3 countries.

Laura PintonVeneto Institute of Oncology IOV - IRCCS, Padova, Italy.
Elena MasettoVeneto Institute of Oncology IOV - IRCCS, Padova, Italy.
Marina VettoreDepartment of Surgery, Oncology and Gastroenterology, University of Padova, Via Gattamelata, 64 35128, Padova, Italy.
Samantha SolitoDepartment of Surgery, Oncology and Gastroenterology, University of Padova, Via Gattamelata, 64 35128, Padova, Italy.
Sara MagriDepartment of Surgery, Oncology and Gastroenterology, University of Padova, Via Gattamelata, 64 35128, Padova, Italy.
Marta D'AndolfiDepartment of Surgery, Oncology and Gastroenterology, University of Padova, Via Gattamelata, 64 35128, Padova, Italy.
Paola Del BiancoVeneto Institute of Oncology IOV - IRCCS, Padova, Italy.
Giovanna LolloLUNAM Universite - Micro et Nanomedecines Biomimetiques, F-49933, Angers, France.
Jean-Pierre BenoitINSERM U1066/CNRS 6021 University of ANGERS, cedex 9, 49933, Angers, France.
Hideho OkadaDepartment of Neurological Surgery, University of California, San Francisco, CA, USA.
Aaron DiazDepartment of Neurological Surgery, University of California, San Francisco, CA, USA.
Alessandro Della PuppaNeurosurgery Unit, Azienda Ospedaliera di Padova, Padova, Italy.
Susanna MandruzzatoVeneto Institute of Oncology IOV - IRCCS, Padova, Italy. susanna.mandruzzato@unipd.it.ORCID 0000-0002-0707-995X
University of Padua · ITIstituto Oncologico Veneto · ITUniversity of California, San Francisco · USAzienda Ospedale - Università Padova · ITCentre National de la Recherche Scientifique · FRUniversité Claude Bernard Lyon 1 · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSystemic and local immune suppression plays a significant role in glioma progression. Glioma microenvironment contains both brain-resident microglial cells (MG) and bone marrow-derived macrophages (BMDM), but the study of their functional and immune regulatory activity has been hampered until now by the lack of markers allowing a proper identification and isolation to collect pure populations.

methodsMyeloid and lymphoid infiltrate were characterized in grade II, III and IV gliomas by multicolor flow cytometry, along with the composition of the cell subsets of circulating myeloid cells. Macrophages were sorted and tested for their immunosuppressive ability. Moreover, following preoperative administration of 5-aminolevulinic acid to patients, distinct areas of tumor lesion were surgically removed and analyzed, based on protoporphyrin IX fluorescence emission.

resultsThe immune microenvironment of grade II to grade IV gliomas contains a large proportion of myeloid cells and a small proportion of lymphocytes expressing markers of dysfunctional activity. BMDM and resident MG cells were characterized through a combination of markers, thus permitting their geographical identification in the lesions, their sorting and subsequent analysis of the functional characteristics. The infiltration by BMDM reached the highest percentages in grade IV gliomas, and it increased from the periphery to the center of the lesion, where it exerted a strong immunosuppression that was, instead, absent in the marginal area. By contrast, MG showed little or no suppression. Functional differences, such as iron metabolism and phagocytosis, characterized resident versus blood-derived macrophages. Significant alterations in circulating monocytes were present in grade IV patients, correlating with accumulation of tumor macrophages.

conclusionsGrade IV gliomas have an alteration in both circulating and tumor-associated myeloid cells and, differently from grade II and III gliomas, show a significant presence of blood-derived, immune suppressive macrophages. BMDM and MG have different functional properties.

Indexed as

AdultAgedAged, 80 and overBiomarkersBrain NeoplasmsFemaleGliomaHumansImmune ToleranceImmunity, InnateImmunocompromised HostImmunohistochemistryMacrophagesMagnetic Resonance ImagingMaleMicrogliaBiomarkersBrain cancerImmunological toleranceInnate immunityTumor immunologyTumor microenvironment

Identifiers

PMID30813960
PMCPMC6391795
OpenAlexW2918868904

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.